Growing community of inventors

Cambridge, MA, United States of America

Karin Briner

Average Co-Inventor Count = 12.48

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Karin BrinerPhilipp Grosche (2 patents)Karin BrinerAlec Nathanson Flyer (2 patents)Karin BrinerLauren Gilchrist Monovich (2 patents)Karin BrinerRui Zheng (2 patents)Karin BrinerTajesh Jayprakash Patel (2 patents)Karin BrinerAndrei Alexandrovich Golosov (2 patents)Karin BrinerJustin Yik Ching Mao (2 patents)Karin BrinerLiansheng Su (2 patents)Karin BrinerEugene Yuejin Liu (2 patents)Karin BrinerBrian Addison Dechristopher (2 patents)Karin BrinerLihua Yang (2 patents)Karin BrinerCarina Cristina Sanchez (1 patent)Karin BrinerKarin Briner (2 patents)Philipp GroschePhilipp Grosche (16 patents)Alec Nathanson FlyerAlec Nathanson Flyer (13 patents)Lauren Gilchrist MonovichLauren Gilchrist Monovich (12 patents)Rui ZhengRui Zheng (11 patents)Tajesh Jayprakash PatelTajesh Jayprakash Patel (9 patents)Andrei Alexandrovich GolosovAndrei Alexandrovich Golosov (9 patents)Justin Yik Ching MaoJustin Yik Ching Mao (5 patents)Liansheng SuLiansheng Su (4 patents)Eugene Yuejin LiuEugene Yuejin Liu (3 patents)Brian Addison DechristopherBrian Addison Dechristopher (2 patents)Lihua YangLihua Yang (2 patents)Carina Cristina SanchezCarina Cristina Sanchez (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (2 from 3,923 patents)


2 patents:

1. 11813306 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders

2. 11026993 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/8/2026
Loading…